Phaseline

Companies › Oui Therapeutics

Oui Therapeutics: clinical trials, targets and expected readouts

1 active drug program in 1 registered trial: 1 Phase 2; Psychiatry.

Open in Phaseline: competitors, likelihood bands and readouts Company report

Programs

DrugTargetHighest phaseConditionsNext expected readout
OTX-601 Digital Therapeutic
Digital therapeutic app delivering evidence-based treatment for PTSD
–Phase 2PTSD–

Trials

Registry idDrugPhaseConditionsAreaExpected readout
NCT07316088OTX-601 Digital TherapeuticPhase 2PTSDPsychiatryJul 2026

Targets

No annotated target.

Companies with the same targets

–

Companies built like this

ProofPilot Samuel Fortin NeuroRx Bazelet Nehushtan Autobahn Therapeutics

Pipelines of the same shape: areas, drug types, target families, stage and cash runway.

Programs group the company's trials by drug; the target and mechanism come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood, shown as a band with its track record, is in the app.